Stock Ratings / Industrials / MLAB / financials

EOSE (28) ENVX (31) KRNT (50) GHM (52) ⌘ Pro Terminal →

Mesa Laboratories Inc. (MLAB) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$133.03 +1.30% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $133.09

Mesa Laboratories Inc. (MLAB) carries a Roarable Rating of D+ (Sell) with 55/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $744.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on MLAB Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is MLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, Mesa Laboratories Inc. (NASDAQ: MLAB) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $133.03 (+1.30% 1D, market cap $744.4M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 485 tracked Industrials issuers, MLAB ranks #243 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does MLAB compare to EOSE and ENVX in the Industrials sector?

▼

Within the Industrials sector (Industrial Machinery/Components), MLAB carries a Roarable D+ (55/100 RQD), trailing P/E of 110.9x, gross margin of 63.5%, and ROIC of 9.3%. By comparison, EOSE (Eos Energy Enterprises Inc. (Class A)) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $721.1M) and ENVX (Enovix Corporation) posts a E grade (31/100 RQD, P/E N/A, ROIC -20.5%, cap $770.3M). Among the 5-stock peer group, GHM leads on earnings multiple (67.3x) while GHM leads on capital efficiency (10.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for MLAB?

▼

Per MLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0000724004), Mesa Laboratories Inc. generated $249.1M in revenue (+3.4% YoY), $6.7M in net income, and $39.6M in free cash flow against $434.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Industrials with deep daily trading liquidity.. Primary risk factors monitored: Priced at 111x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $133.08 (+0.04%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 15.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY • 51.4% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-1.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MLAB)Realized 20D OHLCV Swing Band: ±8.1%

Deterministic 5-Pillar Attribution (55/100 Composite)

🔍 WHY MLAB SCORES 55/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (25% of score)

Altman Z-Score 2.07 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Macro Regime Fit+12/20 pts (22% of score)

FRED Regime × Technicals: 85% of 52W Range • RSI-14 at 49 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Whale & Options Positioning8/20 pts (-12 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$127.51-3.9% Next Q

Q2 (-2Q)

Grade C-$122.48+5% Next Q

Q3 (-1Q)

Grade C-$128.66+3.4% Next Q

Current

Grade D+$133.03-0.5% Hist 90D α

Trajectory: D (47) → D+ (55)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the MLAB Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 55/100 (D+) score, MLAB faces multiple-compression risk if 110.9x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 111x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 61.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($128.52) or 200D SMA ($104.18) invalidates the momentum regime and cuts Target Base ($131.23) toward Bear Floor ($102.36).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MLAB• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MLAB Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”

YES 55%NO 45%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How MLAB Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$39.6M (15.9% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $216.2M

FY24

Rev $241.0M

FY25

Rev $249.1M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$249.1M	63.5%	7.4%	$6.7M	$39.6M	9.3%
FY 2024	$241.0M	62.6%	6.8%	-$2.0M	$42.6M	10.1%
FY 2023	$216.2M	63.5%	-80%	-$254.2M	$44.1M	9.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MLAB)

✓Walkthrough of MLAB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MLAB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +33.03%▲ ASCENDING CHANNEL

2026-10-30O $132.4H $133.0L $127.1C $133.0VOL 73.2K

RES: $154.4SUP: $105.9SMA50: $128.5SMA200: $104.2

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MLAB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MLAB Butterfly Map → + Track MLAB →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +3.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MLAB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MLAB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MLAB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MLAB)

Industrials Rank #243 of 485 ⚔️ EOSE vs MLAB Full Matrix →

1. Head-to-Head Industrials Peer Comparison (MLAB vs. EOSE, ENVX, KRNT, GHM)

Industry: Industrial Machinery/Components (208 Tracked Issuers)

Across 485 tracked Industrials securities in the Roarable RQD universe, Mesa Laboratories Inc. (MLAB) ranks #243 by composite RQD confidence (55/100, grade D+) and #273 by equity capitalization ($744.4M). Within this direct 5-issuer industry benchmark cohort, GHM leads on earnings valuation at 67.3x trailing P/E, while GHM leads on capital efficiency and profitability with 10.9% ROIC and 23.5% gross margin. MLAB currently leads its immediate peer cohort in composite quantitative strength at 55/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MLAB ACTIVE Mesa Laboratories Inc.	D+	55/100	110.9x	63.5%	9.3%	+1.30%	$744.4M	Benchmark Subject
EOSE Eos Energy Enterprises Inc. (Class A)	E	28/100	—	-30.0%	-35.0%	+1.54%	$721.1M	/eose-vs-mlab →
ENVX Enovix Corporation	E	31/100	—	19.2%	-20.5%	-0.28%	$770.3M	/envx-vs-mlab →
KRNT Kornit Digital Ltd.	D	50/100	—	44.3%	-4.0%	+0.11%	$780.7M	/krnt-vs-mlab →
GHM Graham Corporation	D+	52/100	67.3x	23.5%	10.9%	+0.75%	$841.4M	/ghm-vs-mlab →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0000724004

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Mesa Laboratories Inc. (MLAB) reported GAAP revenue of $249.1M (+3.4% vs. FY2024 revenue of $241.0M , and +15.2% cumulative change since FY2023) , GAAP net income of $6.7M, operating cash flow of $42.8M, and free cash flow of $39.6M (-7.0% YoY). On the balance sheet, MLAB closed FY2025 with $434.8M in total assets against $0 in total debt (Altman Z-Score: 2.07, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-03-31	$249.1M	$6.7M	$42.8M	$39.6M	$434.8M	—
FY2024 (FY)	2025-03-31	$241.0M	-$2.0M	$46.8M	$42.6M	$433.3M	—
FY2023 (FY)	2024-03-31	$216.2M	-$254.2M	$44.1M	$44.1M	—	—

3. MLAB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does MLAB compare to EOSE and ENVX in the Industrials sector?

What are the biggest fundamental strengths and SEC risk factors for MLAB?

Where is MLAB trading relative to its 50-day, 200-day, and 52-week technical levels?

MLAB last traded at $133.03 (+1.30% on volume of 60,937 shares), positioning the stock +3.51% above its 50-day simple moving average ($128.52) and +27.69% above its 200-day simple moving average ($104.18). Across its 52-week range of $69.51 to $144.35, MLAB sits at the 84.9% percentile with a 14-day RSI of 49.0 (NEUTRAL RANGE) and an implied next-earnings move of ±8.1% ($122.25 to $143.81).

MLAB Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is Mesa Laboratories Inc. (MLAB)?

In FY 2025 (10-K), MLAB converted $249.1M of revenue into a 63.5% gross margin, 7.4% operating margin, and $39.6M in free cash flow (15.9% FCF margin).

Direct Sub-Reports: MLAB RQD Cockpit MLAB 12M Forecast MLAB Earnings & Move MLAB Dividends & DRIP MLAB Insiders & 13F MLAB Whale Options MLAB Profit Sankey MLAB News & Why